UBS Maintains Buy on Morningstar, Lowers Price Target to $260

Benzinga Newsdesk www.benzinga.com Negative 72.1%

Neg 72.1% Neu 0% Pos 0%

UBS analyst Alex Kramm maintains Morningstar (NASDAQ:MORN) with a Buy and lowers the price target from $280 to $260.

Comments

No comments yet. Be the first!